Page last updated: 2024-08-18

pyrroles and Myeloproliferative Disorders

pyrroles has been researched along with Myeloproliferative Disorders in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Campos, AR; Donoghue, DJ; Meyer, AN; Peiris, MN; Warda, D	1
Albom, MS; Angeles, TS; Breslin, HJ; Dorsey, BD; Gingrich, DE; Huang, Z; Lisko, JG; Mason, JL; Milkiewicz, KL; Thieu, TV; Underiner, TL; Weinberg, LR; Wells, GJ; Wells-Knecht, KJ	1
Albitar, M; Cherrington, JM; Cooper, MA; Garcia-Manero, G; Giles, FJ; Hannah, AL; Kantarjian, HM; Karp, JE; Khan, KD; Lancet, JE; Shami, PJ; Silverman, L; Stopeck, AT; Thomas, DA; Zangari, M	1
Birnbaum, D; Chevrier, V; Daviet, L; Delaval, B; Dubreuil, P; Lelièvre, H; Létard, S	1

Trials

1 trial(s) available for pyrroles and Myeloproliferative Disorders

Article	Year
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases. Cancer, 2003, Apr-15, Volume: 97, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Endothelial Growth Factors; Female; Fusion Proteins, bcr-abl; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Middle Aged; Myeloproliferative Disorders; Protein-Tyrosine Kinases; Pyrroles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors	2003

Article

Year

Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases.

Cancer, 2003, Apr-15, Volume: 97, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Endothelial Growth Factors; Female; Fusion Proteins, bcr-abl; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Middle Aged; Myeloproliferative Disorders; Protein-Tyrosine Kinases; Pyrroles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors

2003

Other Studies

3 other study(ies) available for pyrroles and Myeloproliferative Disorders

Article	Year
Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation. Oncotarget, 2022, Volume: 13 Topics: Cell Proliferation; Chromosomes, Human, Pair 8; GRB2 Adaptor Protein; Humans; Lymphoma; Myeloproliferative Disorders; Proteomics; Pyrazoles; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Translocation, Genetic; Ubiquitin-Specific Proteases	2022
2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation. Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24 Topics: Amino Acid Substitution; Glutathione; Humans; Janus Kinase 2; Myeloproliferative Disorders; Protein Kinase Inhibitors; Pyrroles; Structure-Activity Relationship; Triazines	2011
Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome. Cancer research, 2005, Aug-15, Volume: 65, Issue:16 Topics: Animals; Cell Cycle; Cell Growth Processes; Centrosome; G1 Phase; Hematopoietic Stem Cells; Mice; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Phosphorylation; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; S Phase	2005